Wangen (Stock Code: 4771), operating in the biotech and medical industry, announced its revenue for April 2026, totaling 420.175 million yuan. This figure represents a substantial year-on-year increase of 47.3%, indicating strong market demand and potential success of new products.

FACT BOX

  • Source: PR Times
  • Category: News